Beirne Wealth Consulting Services’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.8K | Hold |
|
|||||
|
2025
Q1 | $20.3K | Hold |
|
|||||
|
2024
Q4 | $22.6K | Hold |
|
|||||
|
2024
Q3 | $40.7K | Hold |
|
|||||
|
2024
Q2 | $44.9K | Hold |
|
|||||
|
2024
Q1 | $66.6K | Hold |
|
|||||
|
2023
Q4 | $49K | Hold |
|
|||||
|
2023
Q3 | $63.5K | Hold |
|
|||||
|
2023
Q2 | $63.5K | Hold |
|
|||||
|
2023
Q1 | $67.5K | Hold |
|
|||||
|
2022
Q4 | $52.6K | Hold |
|
|||||
|
2022
Q3 | $51K | Hold |
|
|||||
|
2022
Q2 | $71K | Hold |
|
|||||
|
2022
Q1 | $70K | Hold |
|
|||||
|
2021
Q4 | $110K | Hold |
|
|||||
|
2021
Q3 | $113K | Hold |
|
|||||
|
2021
Q2 | $128K | Hold |
|
|||||
|
2021
Q1 | $106K | Hold |
|
|||||
|
2020
Q4 | $79K | Hold |
|
|||||
|
2020
Q3 | $42K | Sell |
|
|||||
|
2020
Q2 | $61K | Buy |
|
|||||
|
2020
Q1 | $37K | Hold |
|
|||||
|
2019
Q4 | $40K | Hold |
|
|||||
|
2019
Q3 | $44K | Hold |
|
|||||
|
2019
Q2 | $50K | Buy |
|
|||||
|
2019
Q1 | $33K | Buy |
|
|||||
|
2018
Q4 | $18K | Buy |
|